Skip to main content
Courtney Campbell, MD, Cardiology, Dallas, TX, Ohio State University Wexner Medical Center

CourtneyMichelleCampbellMDPhD

Cardiology • Dallas, TX

Medical Director of Center for Cardio-Oncology at Baylor Heart and Vascular Hospital, Dallas

Join to view full profile

Dr. Campbell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Campbell's full profile

Already have an account?

Summary

  • Courtney M. Campbell, MD, PhD is a cardiologist at Cardiology Consultants of Texas and the Medical Director of Cardiology-Oncology at Baylor Scott and White Heart and Vascular Hospital, Dallas. She is an expert in the cardiovascular care of oncology patients and in patients with amyloidosis.

    Cardio-Oncology includes cardiovascular care prior to cancer therapy, during cancer therapy, and throughout cancer survivorship. The discipline focuses on cardiovascular optimization, cardiac monitoring, and preventive cardiovascular care throughout the cancer spectrum. In addition, cardio-oncology aims to minimize disruption in cancer therapy through management of short- and long-term cancer-treated related cardiotoxicity and treatment of acute cardiac issues. Cardio-Oncology is a highly dynamic field as cancer and amyloidosis therapy rapidly evolves.

    Within the Cardiology-Oncology program, we seek to bring the latest advances and approaches to our patients to improve their quality of life via excellent patient care, engagement in clinical trials, and robust clinical-translational research collaborations. As a physician-scientist, Dr. Campbell's research interests are in early diagnostic approaches and intervention in cardio-oncology and amyloidosis through prospective studies, clinical trials, and multidisciplinary collaboration.

    Dr. Campbell was born and raised in Dallas, Texas. She studied History of Science at Harvard University, completing bachelor’s and master’s degrees. She earned her MD and PhD in Pharmacology from Vanderbilt University. As part of the Physician Scientist Training Program, she completed her internal medicine residency and cardiovascular medicine fellowship at The Ohio State University. She then completed additional fellowship training in Cardio-Oncology and Amyloidosis at Washington University in St. Louis and served as an attending (supervising) physician. She is thrilled to be home now in Dallas, serving the community she grew up in.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Cardio-Oncology and Amyloidosis, 2021 - 2022
  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Cardiovascular Disease, 2017 - 2021
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 2015 - 2017
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2015
  • Vanderbilt University Graduate School
    Vanderbilt University Graduate SchoolPhD, Pharmacology, 2007 - 2013
  • Harvard University
    Harvard UniversityMA, History of Science, 2005 - 2006
  • Harvard University
    Harvard UniversityBA, History of Science, Cum Laude, 2002 - 2006

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2021 - 2025
  • OH State Medical License
    OH State Medical License 2015 - 2025
  • TX State Medical License
    TX State Medical License 2022 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • International Cardio-Oncology Society Board Certification in Cardio-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Initiation of Cardiology Care in Cardiac Amyloidosis: A Single Center Experience
    Campbell CM, Mbeng CA, Rodgers B, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Kahwash R, Vallakati A, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
  • Orthopaedics History Preceding Diagnosis of Cardiac Amyloidosis: Timing and Variation by Subtype
    Campbell CM, Mbeng CA, Rodgers B, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, Vallaka..., International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
  • High price and US insurance practices delay and limit access to Tafamidis for patients with transthyretin cardiac amyloidosis: A Single Center Experience.
    Campbell CM, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, Vallkati A, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
  • Join now to see all

Press Mentions

  • ACC Cardio-Oncology Course Drives Discourse, Innovation in Fast-Growing Field
    ACC Cardio-Oncology Course Drives Discourse, Innovation in Fast-Growing FieldOctober 16th, 2020
  • Long Delays in Amyloidosis Dx, Even With Established Cardiac Care
    Long Delays in Amyloidosis Dx, Even With Established Cardiac CareJune 30th, 2020

Professional Memberships

Hospital Affiliations

External Links

  • My bibliographyhttps://www.ncbi.nlm.nih.gov/myncbi/1pWww-vUdydAb/bibliography/public/

Dr. Courtney Campbell, Dr. Courtney Campbell, MD, Dr. C Campbell, Dr. Courtney Michelle Campbell